Fludara (Fludarabine) for Leukemia | MyLeukemiaTeam

Connect with others who understand.

sign up Log in
About MyLeukemiaTeam
Powered By

Fludara is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with B-cell chronic lymphocytic leukemia (CLL). Fludara is often prescribed in combination with other medications as part of a chemotherapy regimen. Fludara may also be referred to by its drug name, fludarabine.

Fludara is an anticancer drug. Fludara is a member of a class of drugs called antimetabolites. Fludara is believed to work by interfering with the DNA synthesis in replicating cells.

How do I take it?
Fludara is administered by intravenous injection on five consecutive days in a 28-day cycle.

Fludara comes in the form of a single-dose vial.

Side effects
The FDA-approved label for Fludara lists common side effects including fever, chills, fatigue, weakness, frequent infections, cough, nausea, vomiting, diarrhea, mouth sores, loss of appetite, and low blood cell counts.

Rare but serious side effects listed for Fludara include autoimmune reactions, lung damage, fetal harm, and severe neurological deficits such as seizures, blindness, and coma. Fludara can also raise the risk for a serious immune condition called graft-versus-host disease in people who receive blood transfusions.

For more details about this treatment, visit:

Fludara — RxList

CLL: Chemotherapy and Drug Therapy — Leukemia and Lymphoma Society

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in